FAZIO, G., V. MASSA, Andrea GRIONI, Vojtěch BYSTRÝ, S. RIGAMONTI, C. SAITTA, M. GALBIATI, C. RIZZARI, C. CONSARINO, A. BIONDI, A. SELICORNI and G. CAZZANIGA. First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia. Journal of clinical pathology. London: BMJ Publishing Group, 2019, vol. 72, No 8, p. 558-561. ISSN 0021-9746. Available from: https://dx.doi.org/10.1136/jclinpath-2019-205707.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia
Authors FAZIO, G., V. MASSA, Andrea GRIONI (380 Italy, belonging to the institution), Vojtěch BYSTRÝ (203 Czech Republic, guarantor, belonging to the institution), S. RIGAMONTI, C. SAITTA, M. GALBIATI, C. RIZZARI, C. CONSARINO, A. BIONDI, A. SELICORNI and G. CAZZANIGA.
Edition Journal of clinical pathology, London, BMJ Publishing Group, 2019, 0021-9746.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30109 Pathology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.460
RIV identification code RIV/00216224:14740/19:00113418
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1136/jclinpath-2019-205707
UT WoS 000478888000009
Keywords in English molecular genetics; haemato-oncology; molecular oncology; paediatric haematology; paediatric pathology
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 31/3/2020 16:50.
Abstract
Cornelia de Lange syndrome (CdLS) is a rare autosomal-dominant genetic disorder characterised by prenatal and postnatal growth and mental retardation, facial dysmorphism and upper limb abnormalities. Germline mutations of cohesin complex genes SMC1A, SMC3, RAD21 or their regulators NIPBL and HDAC8 have been identified in CdLS as well as somatic mutations in myeloid disorders. We describe the first case of a paediatric patient with CdLS with B-cell precursor Acute Lymphoblastic Leukaemia (ALL). The patient did not show any unusual cytogenetic abnormality, and he was enrolled into the high risk arm of AIEOP-BFM ALL2009 protocol because of slow early response, but 3 years after discontinuation, he experienced an ALL relapse. We identified a heterozygous mutation in exon 46 of NIPBL, causing frameshift and a premature stop codon (RNA-Targeted Next generation Sequencing Analysis). The analysis of the family indicated a de novo origin of this previously not reported deleterious variant. As for somatic cohesin mutations in acute myeloid leukaemia, also this ALL case was not affected by aneuploidy, thus suggesting a major impact of the non-canonical role of NIPBL in gene regulation. A potential biological role of NIPBL in leukaemia has still to be dissected.
PrintDisplayed: 25/6/2024 18:39